Effect of verapamil on heart rate variability after an acute myocardial infarction

Cardiovascular Drugs and Therapy

Volumn 12, Issue 3, 1998, Pages 285-290

  Vaage Nilsen, M ^a,b   Rasmusssen, V ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b Mental Health Services CPH   (Denmark)

Author keywords

Heart rate variability; Postinfarction; Verapamil and heart rate variability

Indexed keywords

PLACEBO; VERAPAMIL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED STUDY; DENMARK; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARASYMPATHETIC NERVE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUDDEN DEATH; SYMPATHETIC TONE;

AGED; ANTI-ARRHYTHMIA AGENTS; CIRCADIAN RHYTHM; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; VERAPAMIL;

EID: 0031712951     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007769800723     Document Type: Article

References (36)

1. Kleiger RE, Miller JP, Bigger JT, Moss AJ, and the Multicenter Post-Infarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59: 256-262.
2. Cripps TR, Malik M, Farrell TG, Camm AJ. Prognostic value of reduced heart rate variability after acute myocardial infarction: Clinical evaluation of a new analysis method. Br Heart J 1991;65:14-19.
3. Casolo GC, Stroder P, Signorini C, et al. Heart rate variability during the acute phase of myocardial infarction. Circulation 1992;85:2073-2079.
4. Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992;85:164-171.
5. Bigger JT, Fleiss JL, Rolnitzky LM, Steinman RC. The ability of several short-term measures of RR variability to predict mortality after myocardial infarction. Circulation 1993;88:927-934.
6. Lombardi F, Sandrone G, Pernpruner S, et al. Heart rate variability as an index of sympathovagal interaction after acute myocardial infarction. Am J Cardiol 1987;60:1 239-1245.
7. Bigger JT, Albrecht P, Steinman RC, Rolnitzky LM, Fleiss JL, Cohen RJ. Comparison of time- and frequency domain-based measures of cardiac parasympathetic activity in Holter recordings after myocardial infarction. Am J Cardiol 1989;64:536-538.
8. Pagani M, Lombardi F, Guzzetti S, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986;59:178-193.
9. Hayano J, Sakakibara Y, Yamada A, et al. Accuracy of assessment of cardiac vagal tone by heart rate variability in normal subjects. Am J Cardiol 1991;67:199-204.
10. Magid NM, Eckberg DL, Sprenkle JM. Low dose atropine reduced ventricular vulnerability in normal and ischemic hearts. J Clin Invest 1983;31:261A.
11. Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med 1976;294:1165-1170.
12. Billman G, Schwartz PJ, Stone HL. Baroreceptor reflex control of heart rate: A predictor of sudden cardiac death. Circulation 1982;66:874-880.
13. Yusuf S, Wittes J, Fridmann L. Overview of results of randomised clinical trials in heart disease. Treatment following myocardial infarction. JAMA 1988;260:2088-2093.
14. Bekheit S, Tangella M, EL-Sakr A, Rasheed Q, Craelius W, EL-Sherif N. Use of heart rate spectral analysis to study the effects of calcium channel blockers on sympathetic activity after myocardial infarction. Am Heart J 1990;119:79-85.
15. Molgaard H, Mickley H, Pless P, Bjerregaard P, Moller M. Effects of metoprolol on heart rate variability in survivors of acute myocardial infarction. Am J Cardiol 1993;71: 1357-1359.
16. Hohnloser SH, Klingenheben T, Zabel M, Just H. Effect of sotalol on heart rate variability assessed by Holter monitoring in patients with ventricular arrhythmias. Am J Cardiol 1993;72:67A-71A.
17. Sarma JSM, Singh N, Schoenbaum MP, Venkataraman K, Singh BN. Circadian and power spectral changes of RR and QT intervals during treatment of patients with angina pectoris with nadolol providing evidence for differential autonomic modulation of heart rate and ventricular repolarization. Am J Cardiol 1994;74:131-136.
18. Kontopoulos AG, Athyros VG, Papageorgiou AA, Papadopoulos GV, Avramidis MJ, Boudoulas H. Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patients. Am J Cardiol 1996;77: 242-246.
19. Keeley EC, Page RL, Lange RA, Willard JE, Landau C, Hillis LD. Influence of metoprolol on heart rate variability in survivors of remote myocardial infarction. Am J Cardiol 1996;77:557-560.
20. The Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II - DAVIT II). Am J Cardiol 1990;66: 779-785.
21. The Danish Study Group on Verapamil in Myocardial Infarction. Secondary prevention with verapamil after myocardial infarction. Am J Cardiol 1990;66:331-401.
22. Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction. Am J Cardiol 1992;69:891-898
23. Vaage-Nilsen M, Rasmussen V, Fischer Hansen, et al., DAVIT II. Effect of verapamil on arrhythmias and heart rate during sixteen months after an acute myocardial infarction. Cardiovasc Drugs 1994;8:147-151.
24. Bonaduce D, Petretta M, Ianniciello A, Apicella C, Cavallaro V, Marciano F. Comparison of verapamil versus felodipine on heart rate variability after an acute myocardial infarction. Am J Cardiol 1997;79:564-569.
25. Nayler WG. Basic mechanisms involved in the protection of the ischemic myocardium: The role of calcium antagonists. Drugs 1991;42(Suppl. 2):21-27.
26. Schömig A, Rehmert G, Kurz T, Richardt G. Calcium antagonism and norepinephrine release in myocardial ischemia. J Cardiovasc Pharmacol 1992;20(Suppl. 7):S16-S20.
27. Wallén NH, Held C, Rehnqvist N, Hjemdal P. Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris. Am J Cardiol 1995;75:1-6.
28. Hjemdahl P, Wallén NH. Calcium antagonist treatment, sympathetic activity and platelet function. Eur Heart J 1997; 18(Suppl. A):A36-A50.
29. Bigger JT, Fleiss JL, Rolnitzky, Steinman RC, Schneider WJ. Time course of recovery of heart period variability after myocardial infarction. J Am Coll Cardiol 1991;18:1643-1649.
30. Hull SS, Evans AR, Vanoli E, et al. Heart rate variability before and after myocardial infarction in conscious dogs at high and low risk of sudden death. J Am Coll Cardiol 1990;16:978-985.
31. Vanoli E, De Ferrari GM, Stramba-Badiale M, Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 1991;68:1471-1481.
32. Farrel TG, Paul V, Cripps TR, et al. Baroreflex sensitivity and electrophysiological correlates in patients after acute myocardial infarction. Circulation 1991;83:945-952.
33. Olsson G, Ryden L. Prevention of sudden death using beta-blockers. Review of possible contributory actions. Circulation 1991;84(Suppl. VI):VI133-VI137.
34. Bonaduce D, Petretta M, Piscione F, et al. Influence of reversible segmental left ventricular dysfunction on heart period variability in patients with one-vessel coronary artery disease. J Am Coll Cardiol 1994;24:399-405.
35. Dambrink J-HE, Tuininga YS, van Gilst WH, Peels KH, Lie KI, Kingma JH, for the CATS investigators. Association between reduced heart rate variability and left ventricular dilatation in patients with a first myocardial infarction. Br Heart J 1994;72:514-520.
36. Fischer Hansen J. Verapamil prevents sudden death in patients with increased heart size after an acute myocardial infarction [letter]. Cardiovasc Drugs Ther 1993;7:381-382.